Walleye Capital LLC Cel Sci Corp Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.09 - $5.23 $1,313 - $2,222	-425 Reduced 3.22%	12,757 $39,000
Q2 2022 Aug 08, 2022	SELL	$2.58 - $4.99 $681,367 - $1.32 Million	-264,096 Reduced 95.25%	13,182 $59,000
Q1 2022 May 16, 2022	BUY	$3.93 - $7.7 $849,324 - $1.66 Million	216,113 Added 353.33%	277,278 $1.09 Million
Q4 2021 Mar 03, 2022	BUY	$7.1 - $12.82 $434,271 - $784,135	61,165 New	61,165 $434,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.